Skip to main content

CITADEL ADVISORS LLC

Position in HOWL — Werewolf Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in HOWL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$8,648 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
11 quarters on record

Common Shares in HOWL Over Time

Shares Held

Position Value (USD)

Derivatives in HOWL

reported options exposure · as of Jun 30, 2026
CallValue
$27,000
CallShares
75,000
PutValue
$5,580
PutShares
15,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in HOWL

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,580 15,500
2026-06-30 $27,000 75,000
2026-03-31 $8,648 10,382
2025-09-30 $304,431 154,534
2025-03-31 $13,219 13,600
2025-03-31 $291 300
2024-12-31 $2,960 2,000
2024-12-31 $20,720 14,000
2024-09-30 $1,484 700
2024-09-30 $1,060 500
2024-09-30 $24,394 11,507
2024-06-30 $3,904 1,600
2024-06-30 $3,172 1,300
2024-06-30 $156,047 63,954
2024-03-31 $15,552 2,400
2024-03-31 $47,304 7,300
2024-03-31 $19,913 3,073
2023-12-31 $386 100
2023-12-31 $14,282 3,700
2023-12-31 $83,074 21,522
2022-12-31 $3,485 1,700
2022-12-31 $22,611 11,030
2022-03-31 $88,633 20,144